Artikel ; Online: Antinociceptive Effect of a p-Cymene/β-Cyclodextrin Inclusion Complex in a Murine Cancer Pain Model: Characterization Aided through a Docking Study.
Molecules (Basel, Switzerland)
2023 Band 28, Heft 11
Abstract: ... of compounds such as p-Cymene (PC), a monoterpene with antinociceptive effects. Our aim was to obtain ... characterize, and measure the effect of the complex of p-cymene and β-cyclodextrin (PC/β-CD) in a cancer pain ...
Abstract | Pain is one of the most prevalent and difficult to manage symptoms in cancer patients, and conventional drugs present a range of adverse reactions. The development of β-cyclodextrins (β-CD) complexes has been used to avoid physicochemical and pharmacological limitations due to the lipophilicity of compounds such as p-Cymene (PC), a monoterpene with antinociceptive effects. Our aim was to obtain, characterize, and measure the effect of the complex of p-cymene and β-cyclodextrin (PC/β-CD) in a cancer pain model. Initially, molecular docking was performed to predict the viability of complex formation. Afterward, PC/β-CD was obtained by slurry complexation, characterized by HPLC and NMR. Finally, PC/β-CD was tested in a Sarcoma 180 (S180)-induced pain model. Molecular docking indicated that the occurrence of interaction between PC and β-CD is favorable. PC/β-CD showed complexation efficiency of 82.61%, and NMR demonstrated PC complexation in the β-CD cavity. In the S180 cancer pain model, PC/β-CD significantly reduced the mechanical hyperalgesia, spontaneous nociception, and nociception induced by non-noxious palpation at the doses tested ( |
---|---|
Mesh-Begriff(e) | Humans ; Mice ; Animals ; Cancer Pain ; Cyclodextrins ; Molecular Docking Simulation ; beta-Cyclodextrins/chemistry ; Pain/drug therapy ; Pain/etiology ; Analgesics/pharmacology ; Analgesics/therapeutic use ; Analgesics/chemistry ; Solubility ; Neoplasms |
Chemische Substanzen | 4-cymene (1G1C8T1N7Q) ; betadex (JV039JZZ3A) ; Cyclodextrins ; beta-Cyclodextrins ; Analgesics |
Sprache | Englisch |
Erscheinungsdatum | 2023-05-31 |
Erscheinungsland | Switzerland |
Dokumenttyp | Journal Article |
ZDB-ID | 1413402-0 |
ISSN | 1420-3049 ; 1431-5165 ; 1420-3049 |
ISSN (online) | 1420-3049 |
ISSN | 1431-5165 ; 1420-3049 |
DOI | 10.3390/molecules28114465 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.MO 81: Hefte anzeigen |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.